You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage III small lymphocytic lymphoma

Showing 76 - 100 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma Trial in Worldwide (BMS-986403, Fludarabine, Cyclophosphamide)

Recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Lymphoma
  • Birmingham, Alabama
  • +24 more
Jul 6, 2022

Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer Trial in Nashville (drug, biological,

Not yet recruiting
  • Limited Stage Lung Small Cell Carcinoma
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Nov 10, 2023

Stage III NSCLC Trial (18F FDG PET/CT, CT scan)

Not yet recruiting
  • Stage III Non-small Cell Lung Cancer
  • 18F FDG PET/CT
  • CT scan
  • (no location specified)
Oct 9, 2023

NSCLC Stage III Trial in Shanghai (standar thoracic RT dose, decreased thoracic RT dose)

Recruiting
  • Non-small Cell Lung Cancer Stage III
  • standar thoracic RT dose
  • decreased thoracic RT dose
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai jiaotong univestigy school of medicine
Sep 27, 2022

Chronic Lymphocytic Leukemia, CLL, Relapsed CLL Trial (Dose combination 1-1, dose combination 1-2, Dose combination 1-3)

Withdrawn
  • Chronic Lymphocytic Leukemia
  • +8 more
  • Dose combination 1-1
  • +5 more
  • (no location specified)
Nov 1, 2021

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Leukemia (SLL) Trial in United States (Zanubrutinib, Obinutuzumab,

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Leukemia (SLL)
  • Evanston, Illinois
  • +7 more
Sep 9, 2022

Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

Active, not recruiting
  • Adult Grade III Lymphomatoid Granulomatosis
  • +23 more
  • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Follicular Lymphoma Trial in Australia, China (BGB-10188,

Recruiting
  • Chronic Lymphocytic Leukemia
  • +9 more
  • Adelaide, Australia
  • +12 more
Jan 6, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Relapsed Chronic Lymphocytic Leukemia Trial in Boston (Acalabrutinib,

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +3 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 19, 2022

Aggressive Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-Cell Lymphoma Trial in United States

Active, not recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • +14 more
  • Cholecalciferol
  • Laboratory Biomarker Analysis
  • Scottsdale, Arizona
  • +4 more
Jan 16, 2023

Recurrent Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Recurrent Small

Recruiting
  • Recurrent Chronic Lymphocytic Leukemia
  • +4 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Mar 22, 2022

NSCLC Trial in Tianjing (Envalfolimab subcutaneously injected+Platinum-based doublet chemo intravenous injection,

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Envalfolimab subcutaneously injected+Platinum-based doublet chemotherapy intravenous injection
  • placebo subcutaneously injected +Platinum-based doublet chemotherapy intravenous injection
  • Tianjing, Tianjin, China
    Tianjin cancer hospital
Nov 3, 2023

Non-Hodgkin's Lymphoma, Relapsed, Chronic Lymphoid Leukemia in Relapse, Non-Hodgkin's Lymphoma Refractory Trial in United States

Completed
Has Results
  • Non-Hodgkin's Lymphoma, Relapsed
  • +8 more
  • PBCAR20A
  • +2 more
  • Duarte, California
  • +4 more
Jan 4, 2023

Relapsed/Refractory Chronic Lymphocytic Leukemia and Relapsed/Refractory Small Lymphocytic Lymphoma Trial in Italy, United

Active, not recruiting
Has Results
  • Relapsed/Refractory Chronic Lymphocytic Leukemia and Relapsed/Refractory Small Lymphocytic Lymphoma
  • brexucabtagene autoleucel
  • +2 more
  • Phoenix, Arizona
  • +21 more
Jun 2, 2022

Leukemia, Leukemia, Lymphocytyc, CLL (Chronic Lymphocytic Leukemia) Trial run by the NHLBI (PCI 32765)

Active, not recruiting
Has Results
  • Leukemia
  • +3 more
  • PCI 32765
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 2, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Rochester (Biospecimen Collection, Bone Marrow Aspiration,

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Biospecimen Collection
  • +7 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Feb 1, 2023

Unresectable Non-Small Cell Lung Cancer (Stage III) in Canada

Completed
  • Non-small Cell Lung Cancer
  • Calgary, Alberta, Canada
  • +4 more
Jun 28, 2023

Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Trial in La Jolla (HDMP + rituximab as a means of debulking prior to

Recruiting
  • Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
  • HDMP + rituximab as a means of debulking prior to initiating venetoclax.
  • La Jolla, California
    UCSD Moores Cancer Center
Mar 21, 2022

Leukemia, Lymphocytic, Chronic, B-Cell Trial in Nanjing (JWCAR029 (Relmacabtagene Autoleucel))

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • JWCAR029 (Relmacabtagene Autoleucel)
  • Nanjing, Jiangsu, China
    Jiangsu Province Hospital
Feb 17, 2022

NSCLC Trial in Shanghai (SH-1028 tablets, Placebo SH-1028 tablets)

Recruiting
  • Non-small Cell Lung Cancer
  • SH-1028 tablets
  • Placebo SH-1028 tablets
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Oct 6, 2023

Limited-stage Small Cell Lung Cancer (LS-SCLC) Trial in Jinan (Tifcemalimab injection, toripalimab injection, Placebo for

Not yet recruiting
  • Limited-stage Small Cell Lung Cancer (LS-SCLC)
  • Tifcemalimab injection
  • +3 more
  • Jinan, Shandong, China
    Shandong Cancer Hospital & Institute
Oct 18, 2023

NSCLC Trial (Atezolizumab, Tiragolumab)

Not yet recruiting
  • NSCLC
  • (no location specified)
Apr 5, 2023

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Zanubrutinib)

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma
  • Boston, Massachusetts
  • +2 more
Mar 16, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (Pneumococcal 13-valent Conjugate Vaccine,

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Pneumococcal 13-valent Conjugate Vaccine
  • Pneumococcal Polyvalent Vaccine
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 10, 2022

Stage III Non-small-cell Lung Cancer Trial in Foshan, Guangzhou (other, radiation, drug)

Recruiting
  • Stage III Non-small-cell Lung Cancer
  • Neoadjuvant therapy
  • +4 more
  • Foshan, Guangdong, China
  • +2 more
Oct 25, 2022